A new study suggests wrist-worn sleep trackers may help predict depression relapse weeks early—explore what this means for ...
Most DLBCL relapses are symptomatic and occur outside of routine follow-ups, during unscheduled visits often initiated by patients rather than clinicians. Current follow-up strategies show limited ...
AlloHeme test accurately predicts relapse post-allo-HSCT in AML and MDS, with a median lead time of 36 days. The ACROBAT study involved 287 patients, showing significant predictive value of increased ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Kane: In talking ...
Actigraphy, typically used to measure sleep phase variability and daily activity amplitude, may help identify risk for depression relapse.
R CHOP re treatment offers durable responses in patients with late relapse diffuse large b cell lymphoma, with a 2-year time ...
Objectives Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is a systemic autoimmune disease where infections ...
Relapse prevention is why most people seek treatment, and with opioid use disorders (OUDs), there’s about a 90 percent relapse rate. This article explains why and how specific sayings from self-help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results